MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

NCT00256776 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

269

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Velcade (Bortezomib)
DRUG: Thalidomide
DRUG: Dexamethasone

Sponsor

European Society for Blood and Marrow Transplantation

Collaborators

[object Object]
[object Object]